Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
Abstract Carcinoma of Unknown Primary (CUP) is a heterogeneous and metastatic disease where the primary site of origin is undetectable. Currently, chemotherapy is the only state-of-art treatment option for CUP patients. The molecular profiling of the tumour, particularly mutation detection, offers a...
Guardado en:
Autores principales: | Hamidreza Aboulkheyr Es, Hamid Mahdizadeh, Amir Abbas Hedayati Asl, Mehdi Totonchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1fe39e7ef8448c2826eda7bf9a46cfb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
KRAS mutation: from undruggable to druggable in cancer
por: Lamei Huang, et al.
Publicado: (2021) -
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
por: Mark Manzano, et al.
Publicado: (2018) -
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
por: Matthias Balk, et al.
Publicado: (2021) -
Melanoma Targeted Therapies beyond <i>BRAF</i>-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
por: Karam Khaddour, et al.
Publicado: (2021) -
Identification of druggable cancer driver genes amplified across TCGA datasets.
por: Ying Chen, et al.
Publicado: (2014)